Description
THRYOSEQUENCE TESTING
Base award description: THRYOSEQUENCE TESTING IGF::OT::IGF
Modification chain · 18 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2016-08-03+$216,480= $216,480
- Mod P000012017-04-03-$156,028= $60,452
- Mod P000022017-08-14+$57,500= $117,952
- Mod P000032017-10-25-$10,335= $107,617
- Mod P000042018-08-01+$41,150= $148,767
- Mod P000052019-03-07-$14,120= $134,647
- Mod P000062019-06-05+$64,900= $199,547
- Mod P000072019-07-02+$21,500= $221,047
- Mod P000082019-10-29+$1,985= $223,032
- Mod P000092020-02-28-$3,275= $219,757
- Mod P000102020-03-18+$0= $219,757
- Mod P000112020-04-20+$0= $219,757
- Mod P000122020-07-23+$63,000= $282,757
- Mod P000132021-08-09+$0= $282,757
- Mod P000142021-08-09+$17,315= $300,072
- Mod P000172022-05-27-$7,745= $292,327
- Mod P000152022-10-13-$24,736= $267,590
- Mod P000162022-10-13-$19,445= $248,146
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2016-08-03 | +$216,480 | $216,480 | THRYOSEQUENCE TESTING IGF::OT::IGF |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2017-04-03 | −$156,028 | $60,452 | THRYOSEQUENCE TESTING IGF::OT::IGF |
| Mod P00002· EXERCISE AN OPTION | 2017-08-14 | +$57,500 | $117,952 | THRYOSEQUENCE TESTING IGF::OT::IGF |
| Mod P00003· OTHER ADMINISTRATIVE ACTION | 2017-10-25 | −$10,335 | $107,617 | THRYOSEQUENCE TESTING IGF::OT::IGF |
| Mod P00004· EXERCISE AN OPTION | 2018-08-01 | +$41,150 | $148,767 | THRYOSEQUENCE TESTING IGF::OT::IGF |
| Mod P00005· CHANGE ORDER | 2019-03-07 | −$14,120 | $134,647 | THRYOSEQUENCE TESTING IGF::OT::IGF |
| Mod P00006· EXERCISE AN OPTION | 2019-06-05 | +$64,900 | $199,547 | THRYOSEQUENCE TESTING IGF::OT::IGF |
| Mod P00007· FUNDING ONLY ACTION | 2019-07-02 | +$21,500 | $221,047 | THRYOSEQUENCE TESTING |
| Mod P00008· OTHER ADMINISTRATIVE ACTION | 2019-10-29 | +$1,985 | $223,032 | THRYOSEQUENCE TESTING |
| Mod P00009· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2020-02-28 | −$3,275 | $219,757 | THRYOSEQUENCE TESTING |
| Mod P00010· OTHER ADMINISTRATIVE ACTION | 2020-03-18 | +$0 | $219,757 | THRYOSEQUENCE TESTING |
| Mod P00011· OTHER ADMINISTRATIVE ACTION | 2020-04-20 | +$0 | $219,757 | THRYOSEQUENCE TESTING |
| Mod P00012· EXERCISE AN OPTION | 2020-07-23 | +$63,000 | $282,757 | THRYOSEQUENCE TESTING |
| Mod P00013· OTHER ADMINISTRATIVE ACTION | 2021-08-09 | +$0 | $282,757 | THRYOSEQUENCE TESTING |
| Mod P00014· EXERCISE AN OPTION | 2021-08-09 | +$17,315 | $300,072 | THRYOSEQUENCE TESTING |
| Mod P00017· FUNDING ONLY ACTION | 2022-05-27 | −$7,745 | $292,327 | THRYOSEQUENCE TESTING |
| Mod P00015· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-10-13 | −$24,736 | $267,590 | THRYOSEQUENCE TESTING |
| Mod P00016· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-10-13 | −$19,445 | $248,146 | THRYOSEQUENCE TESTING |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI KC5VWAGMNLT6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25926N0365 | NETWORK CONTRACT OFFICE 19 (36C259) · Q301 · REFERENCE LABORATORY TESTING | $72,000 | FY2026 |
| 36C26126N0502 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · Q301 · REFERENCE LABORATORY TESTING | $72,000 | FY2026 |
| 36C24426N0741 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q301 · REFERENCE LABORATORY TESTING | $67,500 | FY2026 |
| 36C24426D0074 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q301 · REFERENCE LABORATORY TESTING | $0 | FY2026 |
| 36C24226N0332 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · Q301 · REFERENCE LABORATORY TESTING | $60,000 | FY2026 |
| 36C25026P0252 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · Q301 · REFERENCE LABORATORY TESTING | $146,250 | FY2026 |
Other recipients under Q301 from 242-NETWORK CONTRACT OFFICE 02 (36C242) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24226N0689 | CENTRAL TOX LLC | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $79,995 | FY2026 |
| 36C24226N0614 | LABORATORY CORPORATION OF AMERICA | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $2,352,838 | FY2026 |
| 36C24226A0050 | LABORATORY CORPORATION OF AMERICA | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $0 | FY2026 |
| 36C24226N0607 | QUEST DIAGNOSTICS INCORPORATED | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $675,002 | FY2026 |
| 36C24226N0524 | WYOMING COUNTY COMMUNITY HOSPITAL | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $19,400 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24316C0127_3600_-NONE-_-NONE- · retrieved 2026-09-26.